PANW is down 22% over the past year and 10.9% in the last seven days alone. Most people are calling it a victim of AI disruption. I think they're reading the wrong story. At $148.70 with a 12-month target of $220, this looks less like a company in trouble and more like the one company in cybersecurity that actually benefits from the thing everyone else is running from.
The thesis rests on three points.
First, the sell-off is a contagion trade, not a fundamental re-rating. When Anthropic launched Claude Code Security this week, an AI tool that autonomously scans and patches vulnerabilities, the entire sector cratered. CrowdStrike fell 8%, Okta dropped 9%, the cybersecurity ETF hit its lowest level since 2023. PANW got dragged down with it. But Claude Code Security threatens point products, tools that do one job in isolation. PANW's platformization strategy has spent two years systematically replacing exactly those tools. The threat that hurt peers arguably strengthens PANW's core argument to enterprise buyers: consolidate onto one intelligent platform or keep managing a fragmented stack that AI can now probe faster than your vendors can patch it.
Second, the underlying business is performing. Revenue grew 15% last quarter to $2.6 billion. Next-Generation Security ARR, the metric that signals where future revenue is actually coming from, hit $6.3 billion growing 28% organically. PANW has beaten earnings estimates 12 consecutive quarters. Over 1,500 enterprises have fully consolidated onto the platform. These aren't aspirational numbers, they're evidence the model is working.
Third, the CyberArk acquisition, closed just 10 days ago, completes the platform in a way that's underappreciated. Network, cloud, endpoint, identity. All four pillars are now covered. At $25 billion it's the largest deal in cybersecurity history, and yes, it compresses near-term margins. But it removes the last credible gap a competitor or a skeptical CISO could point to.
The near-term concern is digestion, not disruption. Q3 EPS guidance came in light, integration costs are real, and the stock will likely stay range-bound until management demonstrates the CyberArk and Chronosphere acquisitions aren't slowing execution velocity. Remaining Performance Obligations and Next-Gen ARR trajectory in the next two quarters are the numbers to watch.
Key risks. Integration friction across two simultaneous large acquisitions is the primary bear case. If platformization conversion rates slow and free trial periods don't convert to paid revenue at the expected rate, the multiple compresses further. In a bear case where growth decelerates to high single digits and margins stay pressured, I see downside toward $120, roughly 20% from here. Insider selling over the past three months is worth monitoring as a sentiment signal, though institutional ownership remains high.
At $148, PANW trades at a meaningful discount to its consensus target of $220. The sector is being repriced on fear of what AI does to security software. PANW is the one name in the sector that is structurally positioned to absorb that disruption rather than be displaced by it.
Have other thoughts on Palo Alto Networks?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
The user Pancham holds no position in NasdaqGS:PANW. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
